Atomo Diagnostics (AT1) 2021年年度报告「ASX」.pdf

1、Year Ended 30 June 2021Appendix 4E Preliminary Final ReportandAnnual Financial Report Atomo Diagnostics Limited Appendix 4E Preliminary Final Report1.Company detailsName of entity:Atomo Diagnostics LimitedABN:37 142 925 684Reporting period:For the year ended 30 June 2021Previous period:For the year

2、ended 30 June 20202.Results for announcement to the marketAUDRevenues from ordinary activitiesup25.1%to6,715,659$Loss from ordinary activities after tax attributable to the owners ofAtomo Diagnostics Limiteddown(34.7%)to6,021,215$Loss for the year attributable to the owners of Atomo Diagnostics Limi

3、teddown(39.7%)to5,797,563$DividendsNo dividends were paid or proposed during the year ended 30 June 2021(2020:Nil).Comments3.Net tangible assetsReportingPreviousperiodperiodAUD CentsAUD CentsNet tangible assets per ordinary security4.76 6.15 4.Control gained over entitiesNot applicable5.Loss of cont

4、rol over entitiesNot applicable6.Details of associates and joint ventures entitiesNot applicableRefer to the Operating and Financial Review within the Directors Report of the Annual Financial Statements for further commentary on the years results,financial position and likely developments in future

5、years.The net tangible assets/(liabilities)per ordinary security is calculated based on 568,597,807 ordinary shares on issue as at 30 June 2021,and 561,077,807 shares that were on issue as at 30 June 2020(post-share split).Atomo Diagnostics Limited Appendix 4E Preliminary Final Report7.Audit qualifi

6、cation or reviewThe financial statements have been audited and an unqualified opinion has been issued.8.AttachmentsThe Annual Financial Report of Atomo Diagnostics Limited for the year ended 30 June 2021 is attached.9.SignedSignedDate:John KeithChairSydney27 August 2021ABN 37 142 925 684Atomo Diagno